Three-Monthly Long-Acting Formulation of Paliperidone Palmitate is a Dominant Treatment Option, Cost Saving while Adding Qalys, Compared to the One-Monthly Formulation in the Treatment of Schizophrenia in Belgium: A Cost-Utility Study
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2016 |
| Reihe/Periodikum: | Value in Health ; volume 19, issue 7, page A526 ; ISSN 1098-3015 |
| Verlag/Hrsg.: |
Elsevier BV
|
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-28968339 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | http://dx.doi.org/10.1016/j.jval.2016.09.1041 |
